Latest News for: hikma
Edit
Down 22% with a P/E of 9, is Hikma one of the best passive income ...
The Motley Fool 17 Jan 2026
Hikma Pharmaceuticals (LSE ... The falling price means Hikma now looks attractively undervalued, with a price-to-earnings (P/E) ratio of only 9.3 ... Hikma may look cheap but I think it could still get cheaper.
Edit
Hikma achieves B scores in Climate Change and Water Security in 2025 CDP assessment (Hikma Pharmaceuticals plc)
Public Technologies 15 Jan 2026
London, 15 January 2026 - Hikma Pharmaceuticals PLC (Hikma, Group), the multinational pharmaceutical company, announced that it has achieved B scores in both Climate Change and Water Security ...
Edit
Queen Rania visits Hikma Pharmaceuticals in Al Salt
Ammon 13 Jan 2026
Her Majesty Queen Rania Al Abdullah visited Hikma ...
Edit
Queen visits Hikma Pharmaceuticals in Al Salt
Petra 12 Jan 2026
Al Salt, January 12 (Petra) -- Her Majesty Queen Rania Al Abdullah visited Hikma Pharmaceuticals site in Al Salt on Monday, where she met with its employees and learned about the company's initiatives in women empowerment.
Edit
Exploring partnership opportunities with Hikma Pharmaceuticals (Hikma Pharmaceuticals plc)
Public Technologies 07 Jan 2026
Our VP of Group Business Development & Alliances, Faisal Darwazeh, shares insights on what makes Hikma an ideal partner for complex generics, specialty branded products, and biosimilars across North America, Europe and the MENA region.
Edit
Hikma full year 2025 aide memoire (Hikma Pharmaceuticals plc)
Public Technologies 17 Dec 2025
Hikma pre-close aide-memoire, 17 December 2025 ... Hikma has prepared this aide-memoire ahead of entering its close period ... Hikma Rx (formerly Generics) ... Hikma introduced medium term Group guidance on 15 May 2025, and revised this on 6 November 2025..
Edit
Inspiring women of Hikma - Meet Cristina Cagnazzi, Finance Director, Hikma Italy (Hikma Pharmaceuticals plc)
Public Technologies 15 Dec 2025
Edit
Hikma chief executive replaced by former boss after share price weakens
The Independent 15 Dec 2025
.
Edit
Hikma launches TYZAVAN™ (vancomycin injection, USP) in the US (Hikma Pharmaceuticals plc)
Public Technologies 08 Dec 2025
London, 08 December 2025 - Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, today announces the launch of the first-of-its-kind, ready-to-use vancomycin premix with ...
Edit
European Injectables growth: a Q&A with Nassim Rahmani, Associate VP, Commercial Europe & Canada (Hikma Pharmaceuticals plc)
Public Technologies 08 Dec 2025
What is the market opportunity for Hikma's Injectables division in Europe? ... The European generics market represents a significant growth opportunity for Hikma's Injectables division ... Hikma has been ...
Edit
Hikma launches TYZAVAN™ (vancomycin injection, USP) in the US
PR Newswire 08 Dec 2025
8, 2025 /PRNewswire/ -- Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, today announces the launch of the first-of-its-kind, ready-to-use vancomycin premix with ...
Edit
Egypt-UAE Tandem: A Pillar of Regional Stability and Shared Growth
Egyptian Streets 02 Dec 2025
Edit
Jefferies London Healthcare Conference Transcript (Hikma Pharmaceuticals plc)
Public Technologies 27 Nov 2025
Edit
Inspiring women of Hikma - Meet Susana Pereira Sr. Director Quality Systems & Validation – EU & MENA Injectables (Hikma Pharmaceuticals plc)
Public Technologies 24 Nov 2025
Edit
Hikma celebrates 20 years on the London Stock Exchange (Hikma Pharmaceuticals plc)
Public Technologies 20 Nov 2025
). London - 20 November 2025. We're proud to mark 20 years as a publicly listed company on the London Stock Exchange ... Hikma Pharmaceuticals plc published this content on November 20, 2025, and is solely responsible for the information contained herein.
- 1
- 2
- Next page »